Free Republic 2nd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $77,211
95%  
Woo hoo!! And we're now over 95%!! Thank you all very much!! God bless.

Keyword: 0profakevaxhysteria

Brevity: Headers | « Text »
  • SANDRA CARMONA, JOURNALIST AND COMMUNICATION DIRECTOR OF THE MINISTRY OF HEALTH OF LA RIOJA, DIES AT THE AGE OF 42

    01/30/2023 6:13:34 PM PST · by george76 · 25 replies
    NEWSROOM ^ | January 27, 2023 | Khizar
    The world of journalism and politics woke up this Friday with sad news: Sandra Carmona, a 42-year-old journalist from La Rioja, has died suddenly without any previous diagnosed disease. The professional, born in Calahorra and mother of two children, a boy and a girlwould have suffered a heart attack during the night, as reported various media. Graduated in Journalism from the University of the Basque Country, Carmona spent a large part of her career in La Rioja NewspaperPoint Radio Calahorra and Rioja Television (TVR)where she worked as an editor and news presenter since her beginnings in the profession. However, in...
  • 25-Year-Old Doctor of Pharmacy Who Ran Multiple “Vaccine” Clinics Dies Suddenly

    01/15/2023 8:11:36 PM PST · by CFW · 52 replies
    The Liberty Daily ^ | 1/15/23 | J.D. Rucker
    The rising cases of young and otherwise healthy people dying suddenly has claimed another victim with a promising future. According to End Times Headlines: A 25-year-old doctor of Pharmacy died suddenly in Pittsburgh in December, just before her father was rushed to the ICU, loved ones say in a GoFundMe campaign. Dr. Lindsay Ann Heck, 25, died unexpectedly from an unknown cause on Dec. 20, 2022, as stated in her obituary.
  • FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox

    05/21/2022 5:44:16 PM PDT · by Jonty30 · 55 replies
    www.fda.gov ^ | September 24, 2019 | Food and Drug Administration
    The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. This is the only currently FDA-approved vaccine for the prevention of monkeypox disease.